Matrine for Injection is an active ingredient extracted from the traditional Chinese medicinal herbs Sophora flavescens and Sophora root. Basic research has shown that it has antiviral, anti-liver fibrosis, anti-apoptotic (preventing liver cell death), cell membrane stabilization, immunomodulatory, adenosine triphosphatase activation, induction of hepatic microsomal drug-metabolizing enzymes, hepatoprotective, and antioxidant effects. It can also increase bile flow and alleviate jaundice. It has broad prospects for primary applications, particularly in antiviral, anti-liver fibrosis, liver protection, liver enzyme regulation, and jaundice reduction.
Packaging： 600 vials per case
Specifications： 150mg
Shelf Life： 24 months
Approval Number： 国药准字H20040593
Indications： Used for the treatment of chronic hepatitis. It helps to restore abnormal levels of alanine aminotransferase and bilirubin in patients with chronic persistent hepatitis and chronic active hepatitis.
Detail
1. Preferred antiviral medication for hepatitis, with high sales in hospitals.
2. Immunomodulatory and anti-liver fibrosis effects.
3. Recommended for combination therapy in difficult-to-treat leukemia.
4. Available in pre-filled packaging in addition to regular packaging.
5. Covered by health insurance in some provinces and the New Rural Cooperative Medical Scheme.
